Results
| IN CR | MAR 2026 | MAR 2025 | MAR 2024 | MAR 2023 |
|---|---|---|---|---|
| Net Sales | 703.06 | 505.05 | 463.54 | 461.33 |
| Total Expenditure | 651.74 | 465.13 | 440.73 | 446.64 |
| PBIDT (Excl OI) | 51.32 | 39.92 | 22.81 | 14.69 |
| Other Income | 8.71 | 2.52 | 2.61 | 1.12 |
| Operating Profit | 60.03 | 42.44 | 25.42 | 15.81 |
| Interest | 25.70 | 15.77 | 8.94 | 5.40 |
| Exceptional Items | 0.00 | -2.82 | 0.00 | 0.00 |
| PBDT | 34.33 | 23.85 | 16.47 | 10.40 |
| Depreciation | 3.79 | 2.22 | 1.24 | 0.91 |
| Profit Before Tax | 30.54 | 21.63 | 15.23 | 9.50 |
| Tax | 7.17 | 5.68 | 3.77 | 2.46 |
| Provisions and contingencies | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit After Tax | 23.37 | 15.95 | 11.46 | 7.04 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Prior Period Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 23.37 | 15.95 | 11.46 | 7.04 |
| Equity Capital | 24.07 | 24.07 | 24.07 | 24.07 |
| Face Value (IN RS) | 1.00 | 1.00 | 10.00 | 10.00 |
| Reserves | 131.03 | 103.59 | 87.64 | 76.91 |
| Basic Eps After Extraordinary Items | 0.97 | 0.66 | 4.76 | 2.92 |
| Basic Eps Before Extraordinary Items | 0.97 | 0.66 | 0.48 | 0.29 |
| No of Public Share Holdings | 0.00 | 0.00 | 0.00 | 0.00 |
| % of Public Share Holdings | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM% (Excl OI) | 7.30 | 7.90 | 4.92 | 3.18 |
| PBIDTM% | 8.54 | 8.40 | 5.48 | 3.43 |
| PBDTM% | 4.88 | 4.72 | 3.55 | 2.26 |
| PBTM% | 4.34 | 4.28 | 3.29 | 2.06 |
| PATM% | 3.32 | 3.16 | 2.47 | 1.53 |
FAQs
What are the Net Sales of Sudarshan Pharma I in the financial year 2026?
For FY 2026, Sudarshan Pharma I recorded Net Sales of ₹703.06 crores.This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.
What is the Operating Profit of Sudarshan Pharma I in 2026?
The Operating Profit of Sudarshan Pharma I for FY 2026 is ₹60.03 crores. With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.
What is the Profit Before Tax (PBT) of Sudarshan Pharma I in 2026?
In FY 2026, Sudarshan Pharma I posted a Profit Before Tax of ₹30.54 croresIt helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.
What is the Net Profit of Sudarshan Pharma I for 2026?
Sudarshan Pharma I recorded a Net Profit of ₹23.37 crores in FY 2026. It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.
What is the Face Value of Sudarshan Pharma I?
The Face Value of Sudarshan Pharma I shares is 1.It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.
What is the PAT Margin (PATM%) of Sudarshan Pharma I in 2026?
In FY 2026, the PAT Margin of Sudarshan Pharma I is 3.32 %. This metric provides insights into the company's efficiency in generating profits after paying taxes.
How to open a Demat Account with Anand Rathi to invest in Sudarshan Pharma I?
Open a Demat Account with Anand Rathi using the following steps:
1. Enter your basic details in the form.
2. Upload ID proof, PAN card, and bank details.
3. Complete eKYC online.
4. Start investing in Sudarshan Pharma I using our TradeMobi App or Web Trading Platform.